Paxlovid does not reduce long COVID risk in vaccinated individuals, study finds

En­grail Ther­a­peu­tics is rid­ing a neu­ro­science tail­wind. Last year as it set out to raise its lat­est fundrais­ing round, the start­up orig­i­nal­ly tar­get­ed $100 mil­lion

Five distinct suicide profiles that could improve detection and treatment of co-existing health conditions and bolster suicide prevention strategies were identified in a cross-sectional study.